Skip to content

Grantsights original data · Updated October 1, 2026

NIH and NSF Funding Odds Tracker

Every NIH institute's FY2026 payline status, success rates by institute for research grants, R01s, K awards and F fellowships, and NSF funding rates by directorate and division. Each figure comes from NIH's or NSF's own tables and is checked against the source before publication.

NIH success rates: NIH Data Book, FY2021 to FY2025, data last updated February 19, 2026. FY2026 policies: institute pages on grants.nih.gov, read October 1, 2026. NSF: FY2025 agency totals, FY2024 directorate and division rates. The page and CSV are licensed CC BY 4.0.

The short answer

No NIH institute publishes a payline for FY2026. NIH funded 13.0% of research grant applications in FY2025, down from 18.5%, as applications rose 13% and awards fell 20%. New R01s did worse at 9.9%. NSF funded 19% of proposals.

NIH institutes with a published FY2026 payline

0 of 27

NIH ended score cutoffs under its Unified Funding Strategy

NIH research grant success rate, FY2025

13.0%

8,161 of 62,592 applications, down from 18.5%

New R01 success rate, FY2025

9.9%

3,405 of 34,491 new R01 applications

NSF funding rate, FY2025

19%

8,377 of 43,532 proposals, down from 26%

NIH, FY2026

Payline status for every NIH institute

No NIH institute publishes a payline for FY2026. NIH's funding decisions page says institutes "will no longer employ these cutoff points in overall impact scores to determine which applications to fund." Four institutes say so on their own page. The rest describe what they weigh instead, and many publish budget cuts and award-length limits that matter as much as the score. Every page also notes that NIH is operating under a continuing resolution (NOT-OD-26-131).

Table: FY2026 payline status, 27 institutes and programsShow
FY2026 payline status by NIH institute
FICFogarty International CenterPayline: None (NIH-wide)Fogarty funds through its own solicitations only and does not accept unsolicited investigator-initiated applications.FIC policy
NCATSNational Center for Advancing Translational SciencesPayline: None (NIH-wide)Competing award levels follow program and grants-management recommendations. Most continuing grants are paid at 90% during the continuing resolution.NCATS policy
NCCIHNational Center for Complementary and Integrative HealthPayline: None (NIH-wide)Each competing application is assessed individually; aims and budgets can be adjusted and no inflation increases are added.NCCIH policy
NCINational Cancer InstitutePayline: None (stated)New R01s with direct costs over $250,000 in any year are generally funded 17% below the study section's recommended level. Smaller new R01s are cut 6.5% (up to $175,000) or 8.5%.NCI policy
NEINational Eye InstitutePayline: None (stated)Each council round, NEI ranks applications within program areas and builds a funding plan from program recommendations.NEI policy
NHGRINational Human Genome Research InstitutePayline: None (NIH-wide)Parent-announcement R01s are generally funded for four years.NHGRI policy
NHLBINational Heart, Lung, and Blood InstitutePayline: None (stated)Investigator-initiated R01s are funded for up to four years. Early stage investigators and clinical studies that need longer are the exceptions.NHLBI policy
NIANational Institute on AgingPayline: None (NIH-wide)Competing awards are cut 16% on average. R03, R21, R15, R36 and new or early stage investigator awards are exempt.NIA policy
NIAAANational Institute on Alcohol Abuse and AlcoholismPayline: None (NIH-wide)Administrative reductions are applied to the direct costs of all competing grants. Early stage investigators get special consideration.NIAAA policy
NIAIDNational Institute of Allergy and Infectious DiseasesPayline: None (stated)Competing awards can be funded at up to 100% of the approved level. Select R01s are multi-year funded for up to four years.NIAID policy
NIAMSNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPayline: None (NIH-wide)NIAMS is unlikely to fund a PI who already holds more than three active R01-equivalent grants.NIAMS policy
NIBIBNational Institute of Biomedical Imaging and BioengineeringPayline: None (NIH-wide)Parent R01s are capped at four years. ESI and modular budgets are cut about 10%; other budgets about 20%.NIBIB policy
NICHDEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPayline: None (NIH-wide)New competing R01s are reduced 14% on average below the recommended level.NICHD policy
NIDANational Institute on Drug AbusePayline: None (NIH-wide)New and competing awards are held near FY2025 average cost. Renewals generally can't grow more than 10% over the prior award.NIDA policy
NIDCDNational Institute on Deafness and Other Communication DisordersPayline: None (NIH-wide)During the continuing resolution, NIDCD limits new awards. Categorical R01s are paid at 85% of the recommended level, modular R01s at 100%.NIDCD policy
NIDCRNational Institute of Dental and Craniofacial ResearchPayline: None (NIH-wide)Modular R01s are reduced at least 10% below the request; non-modular R01s at least 15%.NIDCR policy
NIDDKNational Institute of Diabetes and Digestive and Kidney DiseasesPayline: None (NIH-wide)R01s averaging under $500,000 a year in direct costs get priority, and PIs with substantial other support are deprioritized. Awards may be trimmed to a four-year average.NIDDK policy
NIEHSNational Institute of Environmental Health SciencesPayline: None (NIH-wide)Priority goes to strategic-plan fit and new, early stage and at-risk investigators. Large unspent balances can trigger budget offsets.NIEHS policy
NIGMSNational Institute of General Medical SciencesPayline: None (NIH-wide)NIGMS is unlikely to give a PI more than one NIGMS R01 and generally prioritizes MIRA (R35) over R01s.NIGMS policy
NIMHNational Institute of Mental HealthPayline: None (NIH-wide)Decisions weigh strategic-plan fit, the full peer review record and portfolio balance, with priority for early stage investigators.NIMH policy
NIMHDNational Institute on Minority Health and Health DisparitiesPayline: None (NIH-wide)Established investigators already holding three R01, P50 or U54 projects across NIH won't be considered. ESI R01s are funded at 100%.NIMHD policy
NINDSNational Institute of Neurological Disorders and StrokePayline: None (NIH-wide)Non-modular R01s take a 20.5% administrative reduction. Applications over $500,000 a year need to meet two of three priority tests.NINDS policy
NINRNational Institute of Nursing ResearchPayline: None (NIH-wide)Competing R01 budgets are cut 10% on average, with no standard cut for early stage investigators.NINR policy
NLMNational Library of MedicinePayline: None (NIH-wide)Modular R01s, R21s and R15s are paid at 90% of the recommended level; categorical R01s at 85%.NLM policy
Common FundNIH Common FundPayline: None (NIH-wide)No standard budget reduction; each funding opportunity sets its own terms.Common Fund policy
ORIPOffice of Research Infrastructure ProgramsPayline: None (NIH-wide)Most K01 and R24 awards are limited to four years.ORIP policy
BRAINBRAIN InitiativePayline: None (NIH-wide)Continuing awards are paid at 90%, except R21, R25, R34 and SBIR/STTR at 100%.BRAIN policy

OBSSR, ODP and THRO also post FY2026 pages, but they co-fund grants that other institutes select and don't take applications directly. Policies are summarized in plain language; read the institute page before planning a budget.

NIH, FY2021 to FY2025

Research project grant success rates by institute

Research project grants (RPGs) cover R01s, R21s, P01s, U01s and the other investigator research mechanisms NIH lists in its definition. In FY2025, NIH reviewed 62,592 RPG applications, 13% more than in FY2024, and made 8,161 awards, 20% fewer. Both moves pushed the rate down at almost every institute. Sorted by FY2025 rate.

Table: research grant success rates, 26 institutes, FY2021 to FY2025Show
NIH research project grant success rates by institute, FY2021 to FY2025
InstituteFY2021FY2022FY2023FY2024FY2025Change, FY2024 to FY2025
All NIH19.1%11,229 of 58,87220.7%11,311 of 54,57121.3%11,052 of 51,88318.5%10,265 of 55,41813.0%8,161 of 62,592-5.5 pts
NIGMS33.4%1,185 of 3,55135.8%1,207 of 3,36836.3%1,150 of 3,16631.5%1,038 of 3,29525.9%1,012 of 3,909-5.6 pts
ORIP25.9%15 of 5827.1%16 of 5934.0%18 of 5334.0%16 of 4722.6%14 of 62-11.4 pts
NIDCR21.8%198 of 91021.0%184 of 87822.0%191 of 86919.1%173 of 90618.2%177 of 971-0.9 pts
NEI24.8%300 of 1,20825.6%316 of 1,23526.2%310 of 1,18326.7%329 of 1,23317.6%240 of 1,362-9.1 pts
NIDCD24.0%180 of 75025.0%191 of 76426.9%183 of 68025.0%186 of 74417.5%155 of 888-7.5 pts
FIC13.8%22 of 15920.9%29 of 13922.3%21 of 9419.8%18 of 9116.8%18 of 107-3.0 pts
NHLBI20.5%916 of 4,47921.3%984 of 4,62121.1%908 of 4,30119.7%952 of 4,83316.6%889 of 5,341-3.1 pts
NIAID17.5%1,582 of 9,06117.3%1,230 of 7,12620.8%1,405 of 6,75018.3%1,280 of 7,00115.4%1,202 of 7,792-2.9 pts
NCATS*14.7%19 of 12920.4%37 of 18126.8%52 of 19414.2%45 of 31615.0%46 of 3070.8 pts
NICHD18.4%509 of 2,76617.3%498 of 2,87318.8%500 of 2,65318.9%500 of 2,65114.0%411 of 2,928-4.9 pts
NIDA14.7%309 of 2,10619.5%406 of 2,08522.1%399 of 1,80819.3%382 of 1,98413.6%302 of 2,215-5.7 pts
NIEHS14.4%144 of 99716.7%160 of 96015.1%134 of 88516.4%165 of 1,00813.0%125 of 961-3.4 pts
NIBIB17.2%217 of 1,26021.5%239 of 1,11017.7%187 of 1,05616.1%175 of 1,08412.8%188 of 1,464-3.3 pts
NIAMS17.6%272 of 1,54718.4%285 of 1,55117.8%241 of 1,35518.0%250 of 1,39212.5%175 of 1,401-5.5 pts
NIAAA17.1%143 of 83527.1%204 of 75230.5%219 of 71722.6%148 of 65512.4%87 of 703-10.2 pts
NIDDK22.6%788 of 3,49321.1%641 of 3,04522.8%706 of 3,09520.5%672 of 3,27612.0%422 of 3,528-8.5 pts
NINDS19.7%857 of 4,34621.8%947 of 4,35020.9%904 of 4,31915.9%736 of 4,62611.5%597 of 5,187-4.4 pts
NIMH22.1%647 of 2,92324.3%673 of 2,76921.7%579 of 2,67121.1%609 of 2,89010.7%351 of 3,271-10.4 pts
NINR12.6%67 of 53315.4%60 of 39016.9%54 of 31915.7%54 of 3459.9%28 of 284-5.8 pts
NCI13.7%1,333 of 9,70115.2%1,358 of 8,93215.9%1,369 of 8,61813.7%1,245 of 9,1179.6%973 of 10,156-4.1 pts
NLM11.9%36 of 30315.3%35 of 22914.8%25 of 16913.1%29 of 2218.4%25 of 299-4.7 pts
NIA24.2%1,073 of 4,43325.3%1,158 of 4,58224.0%1,057 of 4,40218.0%922 of 5,1308.0%511 of 6,378-10.0 pts
NHGRI24.7%140 of 56725.1%97 of 38622.0%96 of 43719.6%89 of 4557.3%47 of 645-12.3 pts
NCCIH*11.1%45 of 40414.8%46 of 31114.4%43 of 29916.0%49 of 3067.1%25 of 351-8.9 pts
Common Fund8.8%140 of 1,59511.8%121 of 1,02614.6%166 of 1,1387.2%85 of 1,1875.9%81 of 1,377-1.3 pts
NIMHD*11.2%84 of 75017.2%137 of 79718.8%120 of 63713.5%79 of 5863.7%25 of 670-9.8 pts

* NIH's table marks the FY2025 rows for NCATS, NCCIH, NIMHD with asterisks but its workbook doesn't say why. Treat those rates with extra care. NIH's separate Type 1 Diabetes program row (35 of 35 funded in FY2025) is in the CSV but left out here.

NIH, FY2023 to FY2025

R01 success rates by institute

Across NIH, 11.3% of R01 and R37 applications were funded in FY2025, down from 16.6% in FY2024 and 19.1% in FY2023. New R01s, the first-time applications most investigators care about, did worse at 9.9%. The R01 and R37 columns add new, renewal and revision applications together, the closest public match to an institute's R01 count. Gray cells have fewer than 20 applications.

Table: R01 success rates, 25 institutesShow
R01 success rates by NIH institute
InstituteR01 and R37, FY2023FY2024FY2025New R01s only, FY2025
NIGMS23.2%363 of 1,56314.4%212 of 1,4778.3%110 of 1,3236.1%66 of 1,087
ORIP15.4%2 of 1325.0%1 of 414.3%1 of 716.7%1 of 6
NIDCR17.5%75 of 42917.2%80 of 46512.6%65 of 51711.1%52 of 469
NEI26.5%223 of 84026.7%233 of 87416.8%160 of 95512.8%98 of 765
NIDCD27.1%121 of 44623.9%118 of 49416.8%96 of 57113.7%65 of 473
FIC31.8%7 of 2223.5%8 of 3412.5%3 of 2412.5%3 of 24
NHLBI19.8%714 of 3,59818.6%728 of 3,91415.5%693 of 4,47614.6%596 of 4,094
NIAID17.8%632 of 3,55716.2%593 of 3,65414.5%580 of 3,99212.8%462 of 3,613
NICHD17.0%259 of 1,52617.6%270 of 1,53115.3%249 of 1,62814.1%212 of 1,508
NIDA21.1%207 of 98016.8%171 of 1,01712.1%139 of 1,15011.5%125 of 1,089
NIEHS13.7%72 of 52613.9%87 of 62612.4%72 of 58011.9%66 of 553
NIBIB21.2%95 of 44820.6%85 of 41216.8%101 of 60116.1%88 of 545
NIAMS16.5%139 of 84416.7%151 of 90614.6%144 of 98413.5%121 of 896
NIAAA29.4%131 of 44519.7%81 of 41113.6%61 of 45014.2%58 of 408
NIDDK20.6%554 of 2,68718.7%529 of 2,82410.4%330 of 3,1609.0%253 of 2,823
NINDS18.8%484 of 2,56915.4%432 of 2,8149.9%321 of 3,2498.6%251 of 2,932
NIMH20.3%329 of 1,62222.1%393 of 1,77910.0%196 of 1,9589.3%169 of 1,823
NINR21.4%40 of 18715.3%34 of 2229.8%19 of 1949.4%18 of 191
NCI16.4%912 of 5,56112.8%746 of 5,8269.0%594 of 6,6366.9%432 of 6,278
NLM17.9%22 of 12313.1%22 of 1688.5%17 of 1998.2%15 of 184
NIA18.8%473 of 2,51114.6%425 of 2,9065.4%206 of 3,8055.0%183 of 3,645
NHGRI23.1%57 of 24717.0%45 of 26410.6%38 of 3599.1%30 of 328
NCCIHnonenone7.2%11 of 1537.4%11 of 149
Common Fund4.1%6 of 1456.0%7 of 1173.6%6 of 1663.6%6 of 166
NIMHDnonenone4.9%22 of 4474.6%20 of 438

NIGMS funds most investigator research through MIRA (R35) awards, so its R01 rate understates its overall odds. Use its research grant rate above.

NIH, FY2025

K award success rates by institute

NIH-wide in FY2025: K01 22.5%, K08 29.7%, K23 30.5% and K99 19.5%. Institute counts are small, so one year can swing hard. The CSV includes every year from FY2021, so several years can be added together for a steadier rate. Gray cells have fewer than 20 applications.

Table: K01, K08, K23 and K99 success rates, 24 institutesShow
K award success rates by NIH institute, FY2025
InstituteK01K08K23K99
NIGMSnone66.7%2 of 350.0%1 of 216.4%23 of 140
ORIP22.2%2 of 9nonenonenone
NIDCR0.0%0 of 438.5%5 of 1380.0%4 of 518.2%6 of 33
NEInone55.6%5 of 950.0%3 of 630.4%14 of 46
NIDCD0.0%0 of 350.0%3 of 657.1%8 of 1430.0%6 of 20
FIC11.1%1 of 9nonenonenone
NHLBI34.9%22 of 6344.5%49 of 11033.7%56 of 16628.8%40 of 139
NIAID35.5%11 of 3151.6%33 of 6442.9%15 of 3532.3%30 of 93
NICHD27.3%3 of 1123.8%5 of 2138.2%29 of 7622.2%20 of 90
NIDA35.9%23 of 6437.5%3 of 844.2%23 of 5220.4%10 of 49
NIEHS28.6%2 of 740.0%2 of 5100.0%1 of 127.9%12 of 43
NIBIB100.0%1 of 166.7%2 of 30.0%0 of 131.0%9 of 29
NIAMS8.3%2 of 2442.4%14 of 3325.9%7 of 2712.8%5 of 39
NIAAA36.4%8 of 2233.3%1 of 325.0%2 of 829.0%9 of 31
NIDDK32.0%31 of 9736.2%21 of 5836.3%29 of 8021.5%14 of 65
NINDS42.9%3 of 730.5%18 of 5928.0%23 of 8218.5%27 of 146
NIMH11.9%12 of 10125.0%5 of 2020.0%27 of 1356.1%6 of 98
NINR12.5%1 of 8none14.3%1 of 714.3%1 of 7
NCI17.3%9 of 529.3%20 of 214none19.2%64 of 334
NLMnonenonenone0.0%0 of 8
NIA14.4%16 of 11127.8%5 of 1815.5%11 of 717.8%14 of 179
NHGRI60.0%3 of 520.0%1 of 5none28.0%7 of 25
NCCIH0.0%0 of 40.0%0 of 123.1%3 of 130.0%0 of 2
NIMHD2.6%1 of 3933.3%2 of 616.1%5 of 3112.5%2 of 16

NIH, FY2025

F30, F31 and F32 fellowship success rates by institute

NIH-wide in FY2025: F30 32.1%, F31 23.5% and F32 26.4%. Several institutes don't take every fellowship type, which shows here as "none." Gray cells have fewer than 20 applications.

Table: F30, F31 and F32 success rates, 22 institutesShow
F30, F31 and F32 fellowship success rates by NIH institute, FY2025
InstituteF30F31F32
NIGMS66.7%2 of 339.1%18 of 4630.1%52 of 173
NIDCR62.5%5 of 826.3%10 of 3862.5%5 of 8
NEI31.6%6 of 1931.5%23 of 7330.8%8 of 26
NIDCD72.7%8 of 1144.8%30 of 6723.3%10 of 43
NHLBI34.4%32 of 9334.3%115 of 33535.0%49 of 140
NIAID39.4%43 of 10925.5%117 of 45934.3%49 of 143
NICHD42.9%21 of 4925.0%54 of 21640.5%30 of 74
NIDA60.0%9 of 1541.8%46 of 11045.0%9 of 20
NIEHS16.7%1 of 627.5%19 of 690.0%0 of 7
NIBIB0.0%0 of 211.1%1 of 927.3%3 of 11
NIAMS37.5%3 of 818.9%23 of 12216.3%7 of 43
NIAAA25.0%2 of 823.3%20 of 8629.4%5 of 17
NIDDK39.6%21 of 5318.5%47 of 25426.4%24 of 91
NINDS40.0%10 of 2527.3%143 of 52324.7%20 of 81
NIMH28.6%10 of 3517.7%41 of 23214.3%12 of 84
NINR100.0%1 of 123.1%6 of 260.0%0 of 1
NCI25.1%57 of 22715.2%92 of 60517.1%24 of 140
NLMnone7.7%1 of 13none
NIA12.5%10 of 8013.4%35 of 26210.9%10 of 92
NHGRI0.0%0 of 114.8%4 of 2712.5%1 of 8
NCCIH100.0%2 of 233.3%4 of 1233.3%1 of 3
NIMHD20.0%1 of 50.0%0 of 230.0%0 of 5

NSF

NSF funding rates: agency, directorate and division

NSF funded 19% of competitive proposals in FY2025, its lowest rate in the five years below. As of October 1, 2026, neither NSF's FY2027 budget request nor its directorate pages give FY2025 rates by directorate, so the directorate view stops at FY2024. Proposals count in the year NSF decides them, not the year they arrive.

NSF agency-wide funding rate by fiscal year
AgencyFY2021FY2022FY2023FY2024FY2025
All NSF26%11,349 of 43,61728%10,971 of 39,14329%11,058 of 38,34226%10,591 of 40,45419%8,377 of 43,532

Source: NSF FY2025 Agency Financial Report, Table 1.1.

Table: NSF funding rates by directorate, FY2019 to FY2024 (10 directorates)Show

By directorate, FY2019 to FY2024

NSF funding rates by directorate, FY2019 to FY2024
DirectorateFY2019FY2020FY2021FY2022FY2023FY2024
BIOBiological Sciences34%36%30%27%24%19%
CISEComputer and Information Science and Engineering23%25%24%28%29%22%
EDUSTEM Education22%23%20%24%27%24%
ENGEngineering26%26%20%24%25%23%
GEOGeosciences37%42%45%41%44%36%
MPSMathematical and Physical Sciences30%30%30%34%33%27%
SBESocial, Behavioral and Economic Sciences23%25%23%22%23%19%
TIPTechnology, Innovation and Partnershipsn/an/an/a24%29%not published
OIAOffice of Integrative Activities45%36%27%24%24%not published
OISEOffice of International Science and Engineering14%17%29%30%25%not published

FY2019 to FY2023: NSF Merit Review Digest, FY2023, Table 1 series. FY2024: each directorate's funding-rate page. TIP was created in FY2022.

Table: NSF funding rates by division, FY2024 (31 divisions)Show

By division, FY2024

NSF funding rates by division, FY2024
DirectorateDivisionProposalsAwardsFunding rate
BIOBiological Infrastructure (DBI)87811313%
BIOEnvironmental Biology (DEB)82719724%
BIOIntegrative Organismal Systems (IOS)1,32524819%
BIOMolecular and Cellular Biosciences (MCB)74616823%
CISEComputing and Communication Foundations (CCF)1,12031128%
CISEComputer and Network Systems (CNS)2,14847322%
CISEInformation and Intelligent Systems (IIS)2,12231715%
CISEAdvanced Cyberinfrastructure (OAC)70122933%
EDUGraduate Education (DGE)52610620%
EDUResearch on Learning in Formal and Informal Settings (DRL)1,54622915%
EDUUndergraduate Education (DUE)1,72848628%
EDUEquity for Excellence in STEM (EES)55622140%
ENGChemical, Bioengineering, Environmental and Transport Systems (CBET)1,67947929%
ENGCivil, Mechanical and Manufacturing Innovation (CMMI)2,33737517%*
ENGElectrical, Communications and Cyber Systems (ECCS)1,01326426%
ENGEngineering Education and Centers (EEC)33311133%
ENGEmerging Frontiers and Multidisciplinary Activities (EFMA)287248%
GEOAtmospheric and Geospace Sciences (AGS)57626646%
GEOEarth Sciences (EAR)86728633%
GEOOcean Sciences (OCE)60423539%
GEOPolar Programs (OPP)35210630%
GEOResearch, Innovation, Synergies and Education (RISE)51716332%
MPSAstronomical Sciences (AST)1,02718418%
MPSChemistry (CHE)1,14338233%
MPSMaterials Research (DMR)1,23130625%
MPSMathematical Sciences (DMS)2,53365026%
MPSOffice of Strategic Initiatives (OSI)1533322%
MPSPhysics (PHY)62728545%
SBEBehavioral and Cognitive Sciences (BCS)1,21920617%
SBESocial and Economic Sciences (SES)1,15922920%
SBESBE Office of Multidisciplinary Activities (SMA)2436928%

NSF now redirects the CISE, ENG and GEO funding-rate pages to its general statistics dashboard, so those rows link to the Internet Archive copy of NSF's own page. * Civil, Mechanical and Manufacturing Innovation (CMMI): NSF shows 17%, but its own counts give 16.0%.

Before you quote these

Reading the numbers

  • A success rate counts applications, not people. NIH folds a resubmission in the same fiscal year into one application, but an investigator who applies twice in different years counts twice. Your own odds depend on score, fit and program priorities, not the institute average.
  • FY2025 fell on both sides. NIH reviewed 13% more research grant applications than in FY2024 and made 20% fewer awards. A falling rate at an institute can come from either side, so check the counts before reading it as tougher review.
  • No payline doesn't mean the score stopped mattering. Institutes still start from peer review. What changed is that no published percentile guarantees or rules out an award, so the program officer conversation and the budget policy carry more weight.
  • FY2026 rates don't exist yet. NIH posted its FY2025 tables in February 2026. Until the FY2026 tables appear, FY2025 is the latest official rate.
  • NSF and NIH measure different things. NSF counts proposals decided during the year; NIH counts applications reviewed. Don't compare an NSF funding rate with an NIH success rate as if they were the same measure.

Methods

Methods and sources

Every figure comes from NIH's or NSF's own tables and is checked against its source before publication.

Sources, checks, updates and licenseShow
  • NIH success rates. NIH Data Book tables #217, #206, #204, #203 (research project grants by institute; by competing status, institute and activity code; K awards; F fellowships), downloaded from NIH's success rates page. The workbooks were last updated by NIH between February 9, 2026 and February 19, 2026. Success rate is awards divided by applications reviewed, following NIH's success rate definition, which counts an application and its same-year resubmission once.
  • R01 figures. The R01 and R37 columns are a Grantsights sum of NIH's new, renewal and revision rows for those two codes. NIH's formal R01-equivalent definition includes a few more codes, so these won't match that series exactly.
  • FY2026 policies. Each institute's funding policies page on grants.nih.gov, read October 1, 2026. The table paraphrases one decision-relevant point per institute.
  • NSF. FY2021 to FY2025 agency totals from the FY2025 Agency Financial Report; FY2019 to FY2023 directorate rows from the FY2023 Merit Review Digest; FY2024 directorate and division rows from NSF's directorate funding-rate pages (Internet Archive copies for CISE, ENG and GEO).
  • How the figures are checked. A build script downloads every source. It recomputes each NIH rate from NIH's counts and stops if any differs from NIH's own rate column. It compares the Data Book rows with a separate pull made for our institute guides. It confirms every policy sentence and every NSF row appears on its source page, and checks the NSF PDF tables word for word. Nothing publishes if a check fails.
  • Updates and corrections. We'll refresh the tracker when NIH posts FY2026 Data Book tables, when institutes revise FY2026 or FY2027 policies, and when NSF publishes newer directorate rates. Report an error through the contact page.
  • License. The tracker and its CSV are published under a Creative Commons Attribution 4.0 International license (CC BY 4.0). Reuse, adapt and share them, including commercially, with credit to Grantsights and a link to this page. The underlying NIH and NSF figures are public government data.

Cite this dataset

Grantsights. NIH and NSF Funding Odds Tracker. Updated October 1, 2026. https://grantsights.com/research/nih-nsf-funding-odds.

License: CC BY 4.0. Free to reuse with attribution.